7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways

Lee, Nari; Chung, You Chul; Kang, Choon Il; Park, Sung-Min; Hyun, Chang-Gu

doi:10.3390/cosmetics6030041

Submit to this Journal Review for this Journal Edit a Special Issue

Article Menu

...

Open AccessArticle

7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways

¹,

¹,

²,

³ and

^1,*

Department of Chemistry and Cosmetics, Jeju National University, Jeju 63243, Korea

Jeju Indi Inc., Seogwipo-si, Jeju 63635, Korea

R&D Center, CoSeed Bio Pham Co., Chungbuk 28161, Korea

Author to whom correspondence should be addressed.

Cosmetics 2019, 6(3), 41; https://doi.org/10.3390/cosmetics6030041

Received: 13 April 2019 / Revised: 4 July 2019 / Accepted: 5 July 2019 / Published: 8 July 2019

(This article belongs to the Special Issue Anti-aging Properties of Natural Compounds)

View Full-Text Download PDF

Browse Figures

Review Reports Citation Export

Abstract

7,8-dimethoxycoumarin (DMC, C11H10O4), a natural coumarin compound, is present in Citrus plants including Citrus decumana and grapefruit. It is known to have protective effects on the kidneys against Cisplatin and ischemia-reperfusion injury. However, the underlying mechanisms of its inhibitory effects on skin inflammation have not been investigated in vitro. Tumor necrosis factor (TNF)-α is known to be one of the main causative agents of skin inflammation. It induces pro-inflammatory cytokines and chemokines by activating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling. In this study, we investigated the inhibitory effect of DMC on the expression of pro-inflammatory cytokines and chemokines in TNF-α-treated human keratinocyte HaCaT cells. Pretreatment with DMC inhibited TNF-α-treated cytokines (interleukin 6; IL-6) and chemokines (IL-8 and monocyte chemoattractant protein-1). In addition, DMC significantly inhibited TNF-α-treated NF-κB activation and phosphorylation of MAPKs, such as c-Jun N-terminal kinases (JNK) and extracellular-signal-regulated kinase (ERK). These results suggest that DMC may elicit an anti-inflammatory response by suppressing TNF-α-treated activation of NF-κB and MAPK pathways in keratinocytes. Hence, it might be a useful therapeutic drug against skin inflammatory diseases. View Full-Text

Keywords: 7,8-dimethoxycoumarin; human keratinocyte HaCaT cell; skin inflammation; NF-κB; MAPK

▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Share and Cite

MDPI and ACS Style

Lee, N.; Chung, Y.C.; Kang, C.I.; Park, S.-M.; Hyun, C.-G. 7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways. Cosmetics 2019, 6, 41. https://doi.org/10.3390/cosmetics6030041

AMA Style

Lee N, Chung YC, Kang CI, Park S-M, Hyun C-G. 7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways. Cosmetics. 2019; 6(3):41. https://doi.org/10.3390/cosmetics6030041

Chicago/Turabian Style

Lee, Nari, You C. Chung, Choon I. Kang, Sung-Min Park, and Chang-Gu Hyun. 2019. "7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways" Cosmetics 6, no. 3: 41. https://doi.org/10.3390/cosmetics6030041

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

7,8-dimethoxycoumarin Attenuates the Expression of IL-6, IL-8, and CCL2/MCP-1 in TNF-α-Treated HaCaT Cells by Potentially Targeting the NF-κB and MAPK Pathways

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI